About MEAJO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions to authors | Online submission | Subscribe | Advertise | Contact | Login 
Middle East African Journal of Ophthalmology Middle East African Journal of Ophthalmology
Users Online: 379   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others

ORIGINAL ARTICLE

Incidence of endophthalmitis after intravitreal bevacizumab using aliquots prepared On-site in 2 operating rooms in Kuwait

Wani Vivek B, Al-Kandari Jamal, Sabti Khalid, Aljassar Faisal, Qali Hussain, Kumar Niranjan, Uboweja Anilkumar, Al-Sabah Khalid, Diab Fahad A, Al-Rashidi Saleh

Year : 2016| Volume: 23| Issue : 1 | Page no: 64-70

   This article has been cited by
 
1 Safety of Receiving Anti–Vascular Endothelial Growth Factor Intravitreal Injection in Office-Based vs Operating Room Settings
Tong Li, Junran Sun, Jingyu Min, Shuangwen Zhou, Xiaolin Zhu, Huixun Jia, Xiaodong Sun
JAMA Ophthalmology. 2021; 139(10): 1080
[Pubmed]  [Google Scholar] [DOI]
2 Outcomes of three intravitreal injections of bevacizumab given monthly for diabetic macular oedema is a viable treatment for an economically disadvantaged population
Aazambir S. Brar, Vivek B. Wani, Arvind L. Tenagi
African Vision and Eye Health. 2021; 80(1)
[Pubmed]  [Google Scholar] [DOI]
3 Incidence of Acute Endophthalmitis After Intravitreal Bevacizumab Injection at a Tertiary Care Hospital in Lahore
Nasir Ahmed, Hafeez Ur Rehman, Memoona Rafique, Muhammad S Hamza, Huma A Mirza
Cureus. 2021;
[Pubmed]  [Google Scholar] [DOI]
4 2018 Update on Intravitreal Injections: Euretina Expert Consensus Recommendations
Andrzej Grzybowski, Reinhard Told, Stefan Sacu, Francesco Bandello, Elad Moisseiev, Anat Loewenstein, Ursula Schmidt-Erfurth
Ophthalmologica. 2018; 239(4): 181
[Pubmed]  [Google Scholar] [DOI]
5 Bevacizumab
Reactions Weekly. 2016; 1592(1): 47
[Pubmed]  [Google Scholar] [DOI]

 

Read this article